The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Health, Polysubstance Use, and Criminal Justice Involvement Among Adults With Varying Levels of Opioid Use
Open accessAbstract
Importance: Health profiles and patterns of involvement in the criminal justice system among people with various levels of opioid use are poorly defined. Data are needed to inform a public health approach to the opioid epidemic. Objective: To examine the association between various levels of opioid use in the past year and physical and mental health, co-occurring substance use, and involvement in the criminal justice system. Design, Setting, and Participants: This retrospective, cross-sectional analysis used the 2015-2016 National Survey on Drug Use and Health to assess the independent association of intensity of opioid use with health, co-occurring substance use, and involvement in the criminal justice system among US adults aged 18 to 64 years using multivariable logistic regression. Exposures: No opioid use vs prescription opioid use, misuse, or use disorder or heroin use. Main Outcomes and Measures: Self-reported physical and mental health, disability, co-occurring substance use, and past year and lifetime involvement in the criminal justice system. Results: The sample consisted of 78 976 respondents (42 495 women and 36 481 men), representative of 196 280 447 US adults. In the weighted sample, 124 026 842 adults reported no opioid use in the past year (63.2%; 95% CI, 62.6%-63.7%), 61 462 897 reported prescription opioid use in the past year (31.3%; 95% CI, 30.8%-31.8%), 8 439 889 reported prescription opioid misuse in the past year (4.3%; 95% CI, 4.1%-4.5%), 1 475 433 reported prescription opioid use disorder in the past year (0.8%; 95% CI, 0.7%-0.8%), and 875 386 reported heroin use in the past year (0.4%; 95% CI, 0.4%-0.5%). Individuals who reported any level of opioid use were significantly more likely than individuals who reported no opioid use to be white, have a low income, and report a chronic condition, disability, severe mental illness, or co-occurring drug use. History of involvement in the criminal justice system increased as intensity of opioid use increased (no use, 15.9% [19 562 158 of 123 319 911]; 95% CI, 15.4%-16.4%; prescription opioid use, 22.4% [13 712 162 of 61 204 541]; 95% CI, 21.7%-23.1%; prescription opioid misuse, 33.2% [2 793 391 of 8 410 638]; 95% CI, 30.9%-35.6%; prescription opioid use disorder, 51.7% [762 189 of 1 473 552]; 95% CI, 45.4%-58.0%; and heroin use, 76.8% [668 453 of 870 250]; 95% CI, 70.6%-82.1%). In adjusted models, any level of opioid use was associated with involvement in the criminal justice system in the past year compared with no opioid use. Conclusions and Relevance: Individuals who use opioids have complicated health profiles and high levels of involvement in the criminal justice system. Combating the opioid epidemic will require public health interventions that involve criminal justice systems, as well as policies that reduce involvement in the criminal justice system among individuals with substance use disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61602-x · Cited by 21,320
Diagnostic and Statistical Manual of Mental Disorders
Sciacca, F., Knipe, H., & Sharma, R. (2020) · Radiopaedia.org · doi:10.53347/rid-80880 · Cited by 2,361
Increases in drug and opioid-involved overdose deaths – United States, 2010-2015
Rudd, R. A., Seth, P., David, F., & Scholl, L. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm655051e1 · Cited by 2,194
The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction
Kolodny, A., Courtwright, D. T., Hwang, C. S., Kreiner, P., Eadie, J. L., Clark, T. W., & Alexander, G. C. (2015) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031914-122957 · Cited by 1,388
Drug Overdose Deaths in the United States, 1999–2020
Hedegaard, H., Miniño, A., Spencer, M. R., & Warner, M. (2021) · doi:10.15620/cdc:112340 · Cited by 1,283
Relationship between Nonmedical Prescription-Opioid Use and Heroin Use
Compton, W. M., Jones, C. M., & Baldwin, G. T. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1508490 · Cited by 1,044
Medication-Assisted Therapies — Tackling the Opioid-Overdose Epidemic
Volkow, N. D., Frieden, T. R., Hyde, P. S., & Cha, S. S. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1402780 · Cited by 1,015
Han, B., Compton, W. M., Blanco, C., Crane, E., Lee, J., & Jones, C. M. (2017) · Annals of Internal Medicine · doi:10.7326/m17-0865 · Cited by 873
The Nicotine Dependence Syndrome Scale: A multidimensional measure of nicotine dependence
Shiffman, S., Waters, A., & Hickcox, M. (2004) · Nicotine & Tobacco Research · doi:10.1080/1462220042000202481 · Cited by 568
Treatment of opioid-use disorders
Schuckit, M. A. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1604339 · Cited by 540
Jones, C. M. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.01.007 · Cited by 517
Vital Signs: Demographic and Substance Use Trends Among Heroin Users - United States, 2002-2013.
Jones, C. M., Logan, J. E., Gladden, R. M., & Bohm, M. K. (2015) · PubMed Central · Cited by 478
Association Between Mental Health Disorders, Problem Drug Use, and Regular Prescription Opioid Use
Sullivan, M. D., Edlund, M. J., Zhang, L., Unützer, J., & Wells, K. B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.19.2087 · Cited by 434
Becker, W. C., Sullivan, L. E., Tetrault, J. M., Desai, R. A., & Fiellin, D. A. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.09.018 · Cited by 399
Drug Overdose Deaths in the United States, 2003–2023
Garnett, M., Miniño, A., Joyce, M., Driscoll, A., & Valenzuela, C. (2024) · doi:10.15620/cdc/170565 · Cited by 383
Green, T. C., Clarke, J., Brinkley-Rubinstein, L., Marshall, B. D. L., Alexander-Scott, N., Boss, R., & Rich, J. D. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.4614 · Cited by 320
Extended-release naltrexone to prevent opioid relapse in criminal justice offenders
Lee, J. D., Friedmann, P. D., Kinlock, T. W., Nunes, E. V., Boney, T. Y., Hoskinson, R. A., Wilson, D., McDonald, R., Rotrosen, J., Gourevitch, M. N., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505409 · Cited by 315
Prescription Opioid Use among Adults with Mental Health Disorders in the United States
Davis, M. A., Lin, L. A., Liu, H., & Sites, B. D. (2017) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2017.04.170112 · Cited by 270
Nunn, A., Zaller, N., Dickman, S., Trimbur, C., Nijhawan, A., & Rich, J. D. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.06.015 · Cited by 264
The effectiveness of opioid maintenance treatment in prison settings: a systematic review
Hedrich, D., Alves, P., Farrell, M., Stöver, H., Møller, L., & Mayet, S. (2012) · Addiction · doi:10.1111/j.1360-0443.2011.03676.x · Cited by 262
Rich, J. D., McKenzie, M., Larney, S., Wong, J. B., Tran, L., Clarke, J., Noska, A., Reddy, M., & Zaller, N. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62338-2 · Cited by 226
Marsden, J., Stillwell, G., Jones, H., Cooper, A., Eastwood, B., Farrell, M., Lowden, T., Maddalena, N., Metcalfe, C., Shaw, J., et al. (2017) · Addiction · doi:10.1111/add.13779 · Cited by 187
Krawczyk, N., Picher, C. E., Feder, K. A., & Saloner, B. (2017) · Health Affairs · doi:10.1377/hlthaff.2017.0890 · Cited by 169
Wakeman, S. E., & Rich, J. D. (2015) · Journal of Addictive Diseases · doi:10.1080/10550887.2015.1059217 · Cited by 88
McKenzie, M., Nunn, A. S., Zaller, N. D., Bazazi, A. R., & Rich, J. D. (2018) · Journal of Opioid Management · doi:10.5055/jom.2009.0024 · Cited by 66
Maradiaga, J., Nahvi, S., Cunningham, C. O., Sanchez, J., & Fox, A. D. (2015) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2015.11.004 · Cited by 65
Jail Management of Arrestees/Inmates Enrolled in Community Methadone Maintenance Programs
Fiscella, K. A. (2004) · Journal of Heredity · doi:10.1093/jurban/jth147 · Cited by 51
Why It's Inappropriate Not to Treat Incarcerated Patients with Opioid Agonist Therapy
Wakeman, S. E. (2017) · The AMA Journal of Ethic · doi:10.1001/journalofethics.2017.19.9.stas1-1709 · Cited by 37
Fisher, W. H., Clark, R. E., Baxter, J., BARTON, B. A., O’Connell, E., & Aweh, G. N. (2014) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2014.05.002 · Cited by 18
Cited by
Stigma as a fundamental hindrance to the United States opioid overdose crisis response
Tsai, A. C., Kiang, M. V., Barnett, M. L., Beletsky, L., Keyes, K. M., McGinty, E. E., Smith, L. R., Strathdee, S. A., Wakeman, S. E., & Venkataramani, A. S. (2019) · PLOS Medicine · doi:10.1371/journal.pmed.1002969 · Cited by 437
Development of a Cascade of Care for responding to the opioid epidemic.
Williams, A. R., Nunes, E. V., Bisaga, A., Levin, F. R., & Olfson, M. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2018.1546862 · Cited by 332
“I probably got a minute”: Perceptions of fentanyl test strip use among people who use stimulants
Reed, M. K., Roth, A. M., Tabb, L. P., Groves, A. K., & Lankenau, S. E. (2021) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2021.103147 · Cited by 65
Nutritional implications of opioid use disorder: A guide for drug treatment providers
Chavez, M. N., & Rigg, K. K. (2020) · Psychology of Addictive Behaviors · doi:10.1037/adb0000575 · Cited by 38
Metadata
- Authors
- Winkelman, T. N. A., Chang, V. W., & Binswanger, I. A.
- Venue
- JAMA Network Open
- Publisher
- American Medical Association (AMA)
- Published
- 2018-07-06
- Volume
- 1
- Issue
- 3
- Pages
- e180558
- ISSN
- 2574-3805 (ISSN-L)
- OpenAlex
- W2849618949
- Cited by
- 301
- References
- 31
- FWCI
- 25.33
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.